Peter Brenders General Manager, Genzyme, a Sanofi Company
Prior to his most recent appointment at Genzyme, Peter Brenders was President & CEO of BIOTECanada since 2005. Previously, he worked in health and corporate affairs in senior management roles at Genzyme Canada and Schering-Plough Canada. Mr. Brenders also sits on various boards in the biotechnology, health and medical sectors.
Genzyme, develops therapies for the treatment of lysosomal storage diseases, rare diseases and multiple sclerosis in Canada.